LOCALIZATION OF O-GLCNAC MODIFICATION ON THE SERUM RESPONSE TRANSCRIPTION FACTOR

被引:0
|
作者
REASON, AJ
MORRIS, HR
PANICO, M
MARAIS, R
TREISMAN, RH
HALTIWANGER, RS
HART, GW
KELLY, WG
DELL, A
机构
[1] UNIV LONDON IMPERIAL COLL SCI TECHNOL & MED, DEPT BIOCHEM, LONDON SW7 2AZ, ENGLAND
[2] IMPERIAL CANC RES FUND, LONDON WC2A 3PX, ENGLAND
[3] JOHNS HOPKINS UNIV, SCH MED, DEPT BIOL CHEM, BALTIMORE, MD 21205 USA
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A unique form of nucleoplasmic and cytoplasmic protein glycosylation, O-linked GlcNAc, has previously been detected, using Gal transferase labeling techniques, on a myriad of proteins (for review see Hart, G. W., Haltiwanger, R. S., Holt, G. D., and Kelly, W. G. (1989a) Annu. Rev. Biochem. 58, 841-874), including many RNA polymerase II transcription factors (Jackson, S. P., and Tjian, R. (1988) Cell 55, 125-133). However, virtually nothing is known about the degree of glycosylation at individual sites, or, indeed, the actual sites of attachment of O-GlcNAc on transcription factors. In this paper we provide rigorous evidence for the occurrence and locations of O-GlcNAc on the c-fos transcription factor, serum response factor (SRF), expressed in an insect cell line. Fast atom bombardment mass spectrometry (FAB-MS) of proteolytic digests of SRF provides evidence for the presence of a single substoichiometric O-GlcNAc residue on each of four peptides isolated after sequential cyanogen bromide, tryptic, and proline specific enzyme digestion: these peptides are 306VSASVSP312, 274GTTSTIQTAP283, 313SAVSSADGTVLK324 , and 374DSSTDLTQTSSSGTVTLP391. Using an array of techniques, including manual Edman degradation, aminopeptidase, and elastase digestion, together with FAB-MS, the major sites of O-GlcNAc attachment were shown to be serine residues within short tandem repeat regions. The highest level of glycosylation was found on the SSS tandem repeat of peptide (374-391) which is situated within the transcriptional activation domain of SRF. The other glycosylation sites observed in SRF are located in the region of the protein between the DNA binding domain and the transcriptional activation domain. Glycosylation of peptides (274-283) and (313-324) was found to occur on the serine in the TTST tandem repeat and on serine 316 in the SS repeat, respectively. The lowest level of glycosylation was recovered in peptide (306-312) which lacks tandem repeats. All the glycosylation sites identified in SRF are situated in a relatively short region of the primary sequence close to or within the transcriptional activation domain which is distant from the major sites of phosphorylation catalyzed by casein kinase II.
引用
收藏
页码:16911 / 16921
页数:11
相关论文
共 50 条
  • [41] O-GlcNAc Regulation of Pancreatic β-cell Identity through Transcription Factor Pdx1
    Wong, Alicia
    Lockridge, Amber
    Alejandro, Emilyn
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2024, 300 (03) : S300 - S301
  • [42] The Making of a Sweet Modification: Structure and Function of O-GlcNAc Transferase
    Janetzko, John
    Walker, Suzanne
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2014, 289 (50) : 34424 - 34432
  • [43] Chemical biology tools for studying the O-GlcNAc modification of proteins
    Vocadlo, David
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 253
  • [44] O-GlcNAc Modification of Transcription Factor Sp1 Mediates Hyperglycemia-Induced VEGF-A Upregulation in Retinal Cells
    Donovan, Kelly
    Alekseev, Oleg
    Qi, Xin
    Cho, William
    Azizkhan-Clifford, Jane
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (12) : 7862 - 7873
  • [45] O-GlcNAc modification: why so intimately associated with phosphorylation?
    Suresh Mishra
    Sudharsana R Ande
    Neil W Salter
    Cell Communication and Signaling, 9
  • [46] O-GlcNAc Modification Is a Promising Therapeutic Target for Diabetic Retinopathy
    Dong, Wenkang
    Imdad, Laraib
    Xu, Shengnan
    Wang, Yinli
    Liu, Chengzhi
    Song, Shiyu
    Li, Zechuan
    Kong, Ying
    Kong, Li
    Ren, Xiang
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (11)
  • [47] Combining HCD and ETD to Determine Sites of O-Glcnac Modification
    Zhao, Peng
    Viner, Rosa
    Teo, Chin Fen
    Brimble, Sandii
    Horn, David M.
    Wells, Lance
    GLYCOBIOLOGY, 2010, 20 (11) : 1470 - 1470
  • [48] O-GlcNAc in the dark
    Angeliki Chalkiadaki
    Nature Chemical Biology, 2012, 8 (4) : 320 - 320
  • [49] Mapping the sites of O-GlcNAc modification of IRS-1
    Ball, LE
    Berkaw, MN
    Robinson, KA
    Buse, MG
    DIABETES, 2005, 54 : A624 - A624
  • [50] O-GlcNAc modification alters α-synuclein aggregation and neuronal toxicity
    Galesic, Ana
    Levine, Paul
    Balana, Aaron John
    Pratt, Matthew
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2019, 258